MKI67 and breast cancer: Radiomics approaches have been successfully used to predict the Ki-67 index in various types of solid tumors, including breast cancer, non-small cell lung cancer, intrahepatic cholangiocarcinoma, glioma subtypes, and gastric cancer (19–23).